310
Participants
Start Date
May 9, 2014
Primary Completion Date
March 30, 2018
Study Completion Date
March 30, 2018
400 µg Brimonidine Implant
400 µg brimonidine implant in the study eye using Brimo DDS® applicator on Day 1, and every 3 months through Month 21.
Sham
Sham treatment with needleless applicator (no implant) to the study eye on Day 1, and every 3 months through Month 21.
Center for Eye Research Australia, Melbourne
Lions Eye Institute, University of Western Australia, Nedlands
Universita degli Studi di Torino, Torino
Retina Associates of Western New York, Rochester
Mid Atlantic Retina, Wills Eye Retina Surgeons, Philadelphia
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan
IRCCS Ospedale San Raffaele, Milan
"Dir IV Clinica Oculistica di Milano, Ospedale Generale Luigi Sacco ", Milan
Charlotte Eye Ear Nose & Throat Associates, PA, Charlotte
Georgia Retina, Decatur
Southern Vitreoretinal Associates, PL, Tallahassee
Retina Specialty Institute, Pensacola
Service d'Ophtalmologie, Bordeaux
Retina Vitreous Associates of Florida, St. Petersburg
Center for Retina and Macular Disease, Winter Haven
"National Ophthalmic Research Institute Retina Consultants of Southwest Florida", Fort Myers
Universita degli Studi di Padova, Dipartimento di Neuroscienze, Padua
Università di Cagliari (presidio San Giovanni di Dio), Bologna
Raj K. Maturi, MD, Indianapolis
"Universitat Bonn, Abteilung fur Augenheilkunde ", Bonn
STZ Eyetrial, Tübingen
Retina Foundation of the Southwest, Dallas
Texas Retina Associates, Arlington
Strategic Clinical Research Group, LLC, Willow Park
Valley Retina Institute, McAllen
"Austin Retina Associates ", Austin
Retina Research Institute of Texas, Abilene
Retina Consultants of Southern Colorado, PC, Colorado Springs
Retinal Consultants of Arizona, Ltd., Retinal Research Institute, Phoenix
Associated Retina Consultants, Phoenix
University of California, San Diego, Jacobs Retina Center, Shiley Eye Center, La Jolla
"Centre Hospitalier Intercommunal de Creteil ", Créteil
Northern California Retina Vitreous Associates, Mountain View
Casey Eye Institute, Oregon Health and Science University, Portland
Oregon Retina, LLP, Eugene
Università di Cagliari (presidio San Giovanni di Dio), Cagliari
Clinical Research Unit, Level2, Bristol Eye Hospital, Lower Maudlin Street, Bristol
Frimley Park Hospital, Eye clinical trials Unit, Department of Opthalmology, Camberley
Moorfields Eye Hospital, London
Macular Unit, Hospital of St Cross, Rugby
Royal Hallamshire Hospital, Eye Department, Sheffield
Lead Sponsor
Allergan
INDUSTRY